Oncology Nursing Society (ONS)

The Oncology Nursing Society (ONS) is a professional association that represents 100,000 nurses and is the professional home to more than 35,000 members. ONS is committed to promoting excellence in oncology nursing and the transformation of cancer care. Since 1975, ONS has provided a professional community for oncology nurses, developed evidence-based education programs and treatment information, and advocated for patient care, all in an effort to improve the quality of life and outcomes for patients with cancer and their families.

In this fourth installment, Paula reviews relevant data for immunotherapies currently FDA approved for patients with advanced endometrial cancer. Read More ›

Videos

Advancing Nursing Science Through Data Science

By Paula Anastasia, MN, RN, AOCN

ONS 2025 - Endometrial Cancer

In this third installment, Paula will discuss the importance and relevance of data science in advancing the field of nursing. Read More ›

Videos

Treatment of Patients With Advanced Endometrial Carcinoma

By Paula Anastasia, MN, RN, AOCN

ONS 2025 - Endometrial Cancer

In this first installment, Paula will discuss recent data of immunotherapy in patients with advanced endometrial cancer and highlight nursing considerations to help manage side effects. Read More ›

Videos

Importance of Health Equity in Gynecologic Cancers

By Paula Anastasia, MN, RN, AOCN

ONS 2025 - Endometrial Cancer

In this second installment, Paula will discuss a health equity study investigating the association of neighborhood socioeconomic deprivation in patients with gynecologic cancers. Read More ›

Wrap-Up

Emerging Treatment Landscape for Multiple Myeloma

ONS 2023 - Multiple Myeloma: Wrap-Up

New targets and innovative therapies for multiple myeloma were highlighted in two sessions presented at ONS 2023. Read More ›

Wrap-Up

Nursing Considerations for Select Multiple Myeloma Treatments

ONS 2023 - Multiple Myeloma: Wrap-Up

Specific factors to be considered are outlined for the management of multiple myeloma treated with certain therapies. Read More ›

Wrap-Up

Adverse Event Management in Multiple Myeloma

ONS 2023 - Multiple Myeloma: Wrap-Up

Common treatment-related adverse events and management approaches to multiple myeloma were outlined in three separate sessions at the ONS 2023 Congress. Read More ›

Wrap-Up

Shared Decision-Making and Self-Management of Cancer Through Patient Empowerment and Education

ONS 2023 - Multiple Myeloma: Wrap-Up

Approaches to help build healthcare professional and patient relationships and considerations for symptom management by patients with multiple myeloma are discussed. Read More ›

Wrap-Up

Health Disparities in Marginalized Patient Populations with Cancer

ONS 2023 - Multiple Myeloma: Wrap-Up

Healthcare disparities among Black and LGBTQ+ and gender minorities negatively impact clinical outcomes and survivorship. Read More ›

Nursing Implications of Chimeric Antigen Receptor T-Cell Therapy

ONS 2017 – Immunotherapy

Chimeric antigen receptor T-cell therapy is an immunotherapeutic approach that has yielded favorable outcomes in various hematologic malignancies. Educating oncology nurses on how to recognize serious adverse events, such as cytokine release syndrome (CRS), is critical for early intervention and reducing CRS-related deaths. Read More ›

Oncology Nursing Society (ONS)

Page 1 of 3